FacebookTwitterDiggDeliciousStumbleuponGoogle BookmarksRedditNewsvineTechnoratiLinkedinRSS Feed
Print

Continues Tradition of Exciting Prize Drawings and Engagement with Neonatal Nursing Attendees at babyLance™ Safety Heelstick Exhibitor Booth

PHOENIX, ATLANTA and SINGAPORE, Sept. 4—MediPurpose™, a medical product manufacturer and master distributor, today announced it will again host an exhibition booth for its babyLance™ safety heelstick at the National Association of Neonatal Nurses’ 30th Annual Education Conference in Phoenix, September 10–12, 2014.

babyLance safety heelstick logo

The company said NANN’s attendees could expect more of the same exciting daily prize drawings and access to babyLance’s product team as at previous NANN conferences. This year, the company is giving away an Apple iPad 16GB with Wi-Fi, a $100 American Express gift card, and a Michael Kors handbag in daily drawings.

MediPurpose will be at booth #230 on:

  • Wednesday, 10 September from 5:30–7:30 p.m.
  • Thursday, 11 September from 9:30 a.m.–2 p.m.
  • Friday, 12 September from 10 a.m.–2.30 p.m.

Prize drawings will be held each day at the end of each exhibition session.

“We are always excited about attending NANN, and the drawings are a way to say ‘thank you’ to the neonatal nurses that take time from their busy conference schedules to visit us,” said Adeline Yi, babyLance product manager. “It’s a special opportunity to personally connect—and in many cases, reconnect—with the neonatal nurses for whom babyLance was explicitly designed. In fact, their invaluable input and feedback at previous conferences have directly influenced the heelstick device’s features and benefits.”

babyLance neonatal heel incision devices

For example, Yi referenced the white paper, Heelstick Trigger Activation Survey at the 2011 NANN Conference. As described in the paper, MediPurpose was in the thick of a yearlong redesign process for the second version of babyLance, throughout which it regularly sought neonatal nurses’ input and validation for the new neonatal heelstick device.

“Their input at the 2011 NANN conference was a crucial factor in our decision to change the original trigger’s directional style, as well as several other components related to babyLance’s ergonomics, functionality and safety,” said Yi. “Since then, we’ve continued to actively encourage them to better help us achieve their expectations for the ideal heelstick device.”

This year, Yi said that the babyLance team will be seeking neonatal nurses’ input on their experience using babyLance. “Our mission for babyLance is for it to produce an accurate incision that minimizes trauma and produces adequate blood volumes, while also being intuitive and safe to use.”

For more information about babyLance—including no-cost product samples—please visit www.medipurpose.com/babylance.


About MediPurpose

Founded in 1999, MediPurpose is an innovative medical device company headquartered in Singapore, with offices in the United States and Europe.

Known for its popular babyLance™ safety heelstick, SurgiLance™ safety lancet and MediPlus™ advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.

MediPurpose's Innovation division offers angel funding and developmental expertise for new medical device inventors that seek entrance into new medical device markets.

For more information about MediPurpose’s medical products and solutions for inventors, innovators, manufacturers and distributors, please visit www.medipurpose.com.

 

 

 

 

 

Join MediPurpose on FaceBook LinkedIn YouTube Delicious Twitter